Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
SGRY 
Surgery Partners Inc (SGRY)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
10/30/2025: SGRY (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
12 Analysts rated it
Moderately tracked stock, growing coverage, gaining market and investor attention.
1 Year Target Price $30.82
1 Year Target Price $30.82
| 8 | Strong Buy |
| 1 | Buy |
| 3 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -45.78% | Avg. Invested days 22 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 10/30/2025 |
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 2.92B USD | Price to earnings Ratio - | 1Y Target Price 30.82 |
Price to earnings Ratio - | 1Y Target Price 30.82 | ||
Volume (30-day avg) 12 | Beta 1.84 | 52 Weeks Range 18.87 - 31.89 | Updated Date 10/30/2025 |
52 Weeks Range 18.87 - 31.89 | Updated Date 10/30/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -1.43 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -5.57% | Operating Margin (TTM) 14.68% |
Management Effectiveness
Return on Assets (TTM) 3.92% | Return on Equity (TTM) 0.12% |
Valuation
Trailing PE - | Forward PE 21.88 | Enterprise Value 6346439492 | Price to Sales(TTM) 0.9 |
Enterprise Value 6346439492 | Price to Sales(TTM) 0.9 | ||
Enterprise Value to Revenue 1.96 | Enterprise Value to EBITDA 12.15 | Shares Outstanding 128209410 | Shares Floating 68521191 |
Shares Outstanding 128209410 | Shares Floating 68521191 | ||
Percent Insiders 1.45 | Percent Institutions 114.22 |
Upturn AI SWOT
Surgery Partners Inc
Company Overview
History and Background
Surgery Partners, Inc. was founded in 2004. It has grown through acquisitions and organic expansion, focusing on ambulatory surgery centers (ASCs) and surgical hospitals.
Core Business Areas
- Ambulatory Surgery Centers (ASCs): The company owns and operates a network of ASCs that provide a range of surgical and related medical services.
- Surgical Hospitals: Surgery Partners also owns and operates surgical hospitals, offering more complex surgical procedures and inpatient care.
- Ancillary Services: This segment includes a range of services, such as optical services and physician practices.
Leadership and Structure
Wayne DeVeydt serves as the Executive Chairman of the Board. Tom Cowhey is the CEO. The organizational structure is divisional, with leadership overseeing ASC operations, hospital operations, and support functions like finance and marketing.
Top Products and Market Share
Key Offerings
- General Surgery: Includes a variety of common surgical procedures performed in ASCs and hospitals. It is difficult to ascertain specific revenue for this broad category, and market share data is typically segmented by procedure rather than facility type. Competitors include HCA Healthcare, Tenet Healthcare, and other ASC chains and hospital systems.
- Orthopedic Surgery: Orthopedic procedures, such as joint replacements and arthroscopic surgeries. As with general surgery, specific revenue data is not publicly broken down by this procedure. Key competitors are the same as general surgery as well as specialized orthopedic practices.
- Ophthalmology: Eye surgeries, including cataract removal and LASIK. Specific revenue is difficult to ascertain, but represents a significant portion of ASC revenue. Key competitors include national chains and local ophthalmology practices.
Market Dynamics
Industry Overview
The healthcare industry is characterized by rising costs, technological advancements, and increasing demand for outpatient surgical services. The shift towards value-based care and improved patient outcomes is driving consolidation and innovation.
Positioning
Surgery Partners is positioned as a leading provider of outpatient surgical services, focusing on strategic partnerships with physicians and health systems. They focus on quality outcomes and efficiency within their facilities.
Total Addressable Market (TAM)
The total addressable market for outpatient surgical services is estimated to be hundreds of billions of dollars annually in the US. Surgery Partners is positioned to capture a portion of this market by expanding its network and enhancing its service offerings.
Upturn SWOT Analysis
Strengths
- Established network of ASCs and hospitals
- Strategic partnerships with physicians
- Focus on high-acuity surgical procedures
- Strong financial performance in recent years
Weaknesses
- High debt levels
- Dependence on physician referrals
- Exposure to reimbursement changes
- Regulatory compliance risks
Opportunities
- Acquisitions of additional ASCs and hospitals
- Expansion into new geographic markets
- Increased demand for outpatient surgical services
- Development of new service lines
Threats
- Increased competition from other ASC chains and hospitals
- Changes in healthcare regulations and reimbursement rates
- Economic downturn impacting patient volumes
- Rising operating costs
Competitors and Market Share
Key Competitors
- HCA (HCA)
- Tenet Healthcare (THC)
- AmSurg (not publicly traded but previously AMSGAQ)
Competitive Landscape
Surgery Partners competes with large hospital systems, other ASC chains, and independent physician practices. Its competitive advantages include its established network, strategic partnerships, and focus on high-acuity procedures. However, its high debt levels and dependence on physician referrals are potential disadvantages.
Major Acquisitions
Airmid Health Group
- Year: 2023
- Acquisition Price (USD millions): 270
- Strategic Rationale: Expanded existing surgical capabilities and added new ones.
ASC of Manhattan
- Year: 2022
- Acquisition Price (USD millions): 20.3
- Strategic Rationale: Expanded Surgical services for New York population.
Growth Trajectory and Initiatives
Historical Growth: Surgery Partners has grown both organically and through acquisitions. Revenue and adjusted EBITDA have increased substantially over the past decade.
Future Projections: Analysts project continued revenue growth driven by acquisitions and organic expansion. Profitability is expected to improve as the company integrates acquisitions and realizes cost synergies.
Recent Initiatives: Recent initiatives include acquiring new ASCs and hospitals, expanding service lines, and investing in technology to improve operational efficiency.
Summary
Surgery Partners is a growing healthcare company focused on outpatient surgical services. It possesses a strong network of ASCs and hospitals and benefits from increasing demand for outpatient procedures. However, the company's high debt levels and the competitive landscape pose challenges. Successfully integrating acquisitions and managing reimbursement pressures will be key to future success.
Similar Stocks
Sources and Disclaimers
Data Sources:
- Company filings (SEC)
- Industry reports
- Analyst estimates
Disclaimers:
This analysis is for informational purposes only and should not be considered financial advice. Market share estimates are approximate and may vary based on data sources. Financial data and projections are subject to change.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Surgery Partners Inc
Exchange NASDAQ | Headquaters Brentwood, TN, United States | ||
IPO Launch date 2015-10-01 | CEO & Director Mr. J. Eric Evans | ||
Sector Healthcare | Industry Medical Care Facilities | Full time employees 15000 | Website https://www.surgerypartners.com |
Full time employees 15000 | Website https://www.surgerypartners.com | ||
Surgery Partners, Inc., together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery. It offers emergency departments; and ancillary services, such as multi-specialty physician practices, urgent care facilities, and anesthesia services. In addition, it offers single- and multi-specialty facilities. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.